首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Straightforward palladium-mediated synthesis and biological evaluation of benzo [j]phenanthridine-7,12-diones as anti-tuberculosis agents
【24h】

Straightforward palladium-mediated synthesis and biological evaluation of benzo [j]phenanthridine-7,12-diones as anti-tuberculosis agents

机译:直接钯介导的苯并介导的合成和生物学评价[J]菲啶-7,12-致抗结核病药剂

获取原文
获取原文并翻译 | 示例
           

摘要

In 1991, WHO recognized the resurgence of tuberculosis as a global health problem. Although modern chemotherapy is effective against the causative pathogen Mycobacterium tuberculosis, the current drug regimens have failed to eradicate the disease. The success of the pathogen, partially attributed to drug resistance, necessitates the development of novel anti-tuberculosis drugs. Benzo[j]phenanthridine-7,12-diones, tetracyclic derivatives of the natural product benz[g]isoquinoline-5,10-dione, were conveniently synthesized via palladium-catalyzed intramolecular cyclization of N-methanesulfonyl-3-bromo-2-(ary-lamino)methyl-1,4-naphthoquinones. Here we report on the bioactivity of eight benzo[j]phenanthridine-7,12-dione derivatives as candidate drug molecules against M. tuberculosis and on their cytotoxicity on C3A human hepatocytes. The strongest antimicrobial activity (as detected by growth inhibition of bacteria, using luminometry and BACTEC 460-TB) and lowest cytotoxicity was found for 3-methylbenzo [j]phenanthridine-7,12-dione 5e, which was also effective in targeting intracellular M. tuberculosis (in murine J774 macrophages) and was not genotoxic for C3A hepatocytes.
机译:1991年,WHO公认的结核病死灰复燃作为一个全球性的健康问题。尽管现代化疗是针对致病病原体结核分枝杆菌有效,目前的药物治疗方案未能根除疾病。病原体的成功,部分归因于耐药性,必要的新型抗结核药物的开发。苯并[d]菲啶-7,12-二酮,天然产物的四环衍生物苯并〔g〕异喹啉-5,10-二酮,经由N-甲烷磺酰基-3-溴-2-钯催化分子内环化物方便地合成(进制-氨基)甲基-1,4-萘醌。在这里,我们八个苯并[d]菲啶-7,12-二酮衍生物作为针对结核分枝杆菌和它们对C3A的人肝细胞的细胞毒性的候选药物分子的生物活性的报告。最强的抗微生物活性和细胞毒性最低(如使用辉度和BACTEC 460 TB由细菌的生长抑制检测)被发现为3-甲基 - 苯并[j]的菲啶-7,12-二酮5e中,这也是有效的靶向细胞内的中号结核分枝杆菌(以鼠J774巨噬细胞),并没有对基因毒性C3A肝细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号